Evidence map›Paper›PMID 25849121›Full record

ArticleCellular & molecular immunology2016

AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancers.

Zhi Duan, Hui Zheng, Haidan Liu, Ming Li, Min Tang, Xinxian Weng, Wei Yi, Ann M Bode, Ya Cao

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Comparison of Non B-Ig and B-Ig.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Zhi DuanLaboratory of Tumor Molecular Biology, Cancer Research Institute, Central South University, Changsha, Hunan 410008, China.
Hui ZhengInstitutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
Haidan LiuDepartment of Cardiothoracic Surgery, Center of Clinical Gene Diagnosis and Therapy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Ming LiDepartment of Immunology, Xiangya Medical College, Central South University, Changsha, Hunan 410008, China.
Min TangLaboratory of Tumor Molecular Biology, Cancer Research Institute, Central South University, Changsha, Hunan 410008, China.
Xinxian WengLaboratory of Tumor Molecular Biology, Cancer Research Institute, Central South University, Changsha, Hunan 410008, China.
Wei YiLaboratory of Tumor Molecular Biology, Cancer Research Institute, Central South University, Changsha, Hunan 410008, China.
Ann M BodeThe Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
Ya CaoLaboratory of Tumor Molecular Biology, Cancer Research Institute, Central South University, Changsha, Hunan 410008, China.
Central South University · CNMinistry of Education of the People's Republic of China · CNSoochow University · CNUniversity of Minnesota · US

Funding

The function of T Bet in EAEP01NS038037 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI WEINER, HOWARD L · 2000 to 2010
$12.8M
NINDS NIH HHS P01 NS038037
6 · The paper itself

Abstract

Recently, immunoglobulins (Igs) were unexpectedly found to be expressed in epithelial cancers. Immunoglobulin class switching or class switch recombination (CSR) is a natural biological process that alters a B cell's production of antibodies (immunoglobulins) from one class to another. However, the mechanism of CSR of Ig genes in cancer is still unknown. Here, we confirmed by detecting the hallmark of CSR that the Igα gene in cancer underwent CSR. Then we focused on activation-induced cytidine deaminase (AID), a crucial factor for initiating CSR. Further studies using tumor necrosis factor (TNF)-α stimulation and specific inhibitor of NF-κB revealed that TNF-α could increase AID expression through NF-κB signaling. Finally, we demonstrated that AID could co-localize with protein kinase A and bind to the switching (Sα) region of the Igα gene. Overexpression of AID obviously enhanced Igα heavy chain expression and its binding ability to the Sα region. These findings indicated that TNF-α-induced AID expression is involved with CSR in cancer.

Indexed as

Recombination, GeneticAICDA (Activation-Induced Cytidine Deaminase)Cell Line, TumorCytidine DeaminaseEpitheliumHumansImmunoglobulin Class SwitchingImmunoglobulinsNeoplasmsNF-kappa BSignal TransductionTumor Necrosis Factor-alphaAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseImmunoglobulinsNF-kappa BTumor Necrosis Factor-alpha

Identifiers

PMID25849121
PMCPMC4947815
OpenAlexW2004999412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.